nejm glp 1 glp-1 Once-Weekly Mazdutide: Effective for Overweight and Obesity (GLORY-1 Study) Discovery of GLP-1–Based Drugs for

10.1093/alcalc/agaf069 104 PazienzaV.ClementS.PugnaleP.ConzelmanS.FotiM.MangiaA.et al (2007)

Does the genetic test predict which GLP-1 will work

"Despite the widespread morbidity and mortality burden of HFpEF, current treatment options are limited," said corresponding author Nils Krger, MD, of the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Womens Hospital, a founding member of the Mass General Brigham healthcare system

doi:10.1146/annurev-cancerbio-030419-033533

Of note, a gradual dosage increment to 14-mg once-daily oral semaglutide treatment showed superiority in reducing HbA1c compared to 25 mg of empagliflozin (PIONEER 2: baseline HbA1c 8.1%, 1.3% vs